Sustained coronary patency after fibrinolytic therapy as independent predictor of 10-year cardiac survival. Observations from the Antithrombotics in the Prevention of Reocclusion in COronary Thrombolysis (APRICOT) trial

American Heart Journal

Volumn 155, Issue 6, 2008, Pages 1039-1046

  Brouwer, Marc A ^a   Kievit, Peter C ^a   Dieker, Hendrik Jan ^a   Veen, Gerrit ^b   Karreman, Aart J ^b   Verheugt, Freek W A ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FONDAPARINUX; HEPARIN; PLACEBO; SMALL HEAT SHOCK PROTEIN;

ADULT; ANGIOGRAPHY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HAZARD RATIO; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART REINFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; ST SEGMENT ELEVATION; SURVIVAL TIME; VASCULAR PATENCY;

AGED; CORONARY OCCLUSION; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY; VENTRICULAR FUNCTION, LEFT;

EID: 44149084704     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.01.008     Document Type: Article

References (32)

1. Wilson S.H., Bell M.R., Rihal C.S., et al. Infarct artery reocclusion after primary angioplasty, stent placement, and thrombolytic therapy for acute myocardial infarction. Am Heart J 141 (2001) 704-710
2. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 329 (1993) 1615-1622
3. Gibson C.M., Cannon C.P., Piana R.N., et al. Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. J Am Coll Cardiol 25 (1995) 582-589
4. Verheugt F.W., Meijer A., Lagrand W.K., et al. Reocclusion: the flip side of coronary thrombolysis. J Am Coll Cardiol 27 (1996) 766-773
5. Meijer A., Verheugt F.W., Werter C.J., et al. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study. Circulation 87 (1993) 1524-1530
6. White H.D., French J.K., Hamer A.W., et al. Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy. J Am Coll Cardiol 25 (1995) 218-223
7. Brouwer M.A., van den Bergh P.J., Aengevaeren W.R., et al. Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction: results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial. Circulation 106 (2002) 659-665
8. Gibson C.M., Karha J., Murphy S.A., et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials. J Am Coll Cardiol 42 (2003) 7-16
9. Ohman E.M., Califf R.M., Topol E.J., et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. TAMI Study Group. Circulation 82 (1990) 781-791
10. Brouwer M.A., Bohncke J.R., Veen G., et al. Adverse long-term effects of reocclusion after coronary thrombolysis. J Am Coll Cardiol 26 (1995) 1440-1444
11. Bauters C., Delomez M., Van Belle E., et al. Angiographically documented late reocclusion after successful coronary angioplasty of an infarct-related lesion is a powerful predictor of long-term mortality. Circulation 99 (1999) 2243-2250
12. Meijer A., Verheugt F.W., van Eenige M.J., et al. Left ventricular function at 3 months after successful thrombolysis. Impact of reocclusion without reinfarction on ejection fraction, regional function, and remodeling. Circulation 90 (1994) 1706-1714
13. White H.D., Norris R.M., Brown M.A., et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76 (1987) 44-51
14. Sadanandan S., Buller C., Menon V., et al. The late open artery hypothesis-a decade later. Am Heart J 142 (2001) 411-421
15. Hochman J.S., Lamas G.A., Buller C.E., et al. Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med 355 (2006) 2395-2407
16. ISIS-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 2 (1988) 349-360
17. White H.D., Cross D.B., Elliott J.M., et al. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. Circulation 89 (1994) 61-67
18. French J.K., Hyde T.A., Straznicky I.T., et al. Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction. J Am Coll Cardiol 35 (2000) 1516-1524
19. Brodie B.R., Stuckey T.D., Kissling G., et al. Importance of infarct-related artery patency for recovery of left ventricular function and late survival after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 28 (1996) 319-325
20. Hudson M.P., Granger C.B., Topol E.J., et al. Early reinfarction after fibrinolysis: experience from the global utilization of streptokinase and tissue plasminogen activator (alteplase) for occluded coronary arteries (GUSTO I) and global use of strategies to open occluded coronary arteries (GUSTO III) trials. Circulation 104 (2001) 1229-1235
21. Nijland F., Kamp O., Verheugt F.W., et al. Long-term implications of reocclusion on left ventricular size and function after successful thrombolysis for first anterior myocardial infarction. Circulation 95 (1997) 111-117
22. The ASSENT-3 Investigators. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction. Lancet 358 (2001) 605-613
23. Madsen J.K., Grande P., Saunamaki K., et al. Danish multicenter randomized study of invasive versus conservative treatment in patients with inducible ischemia after thrombolysis in acute myocardial infarction (DANAMI). DANish trial in Acute Myocardial Infarction. Circulation 96 (1997) 748-755
24. Andreotti F., Testa L., Biondi-Zoccai G.G., et al. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. Eur Heart J 27 (2006) 519-526
25. Antman E.M., Morrow D.A., McCabe C.H., et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354 (2006) 1477-1488
26. Sabatine M.S., Cannon C.P., Gibson C.M., et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 352 (2005) 1179-1189
27. The OASIS-6 trial group. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction. The OASIS-6 randomized trial. JAMA 295 (2006) 1519-1530
28. Kievit P.C., Brouwer M.A., Veen G., et al. High-grade infarct related stenosis after successful thrombolysis: strong predictor of reocclusion, but not of clinical reinfarction. Am Heart J 148 (2004) 826-833
29. Michels K.B., and Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials. Circulation 91 (1995) 476-485
30. Alonso J.J., Gimeno F., Sanz O., et al. Effect of early posthrombolysis stenting versus conservative approach to STEAMI on one-year angiographic outcome. An angiographic substudy of the GRACIA-1 trial. Circulation 108 (2003) 468
31. Collet J.P., Montalescot G., Le May M., et al. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. J Am Coll Cardiol 48 (2006) 1326-1335
32. Dzavik V., Buller C.E., Lamas G.A., et al. Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial. Circulation 114 (2006) 2449-2457